Agreement

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

Retrieved on: 
Monday, March 11, 2024
Claim, Agreement, Prejudice, Action, Defendant, Summons, Person, Fee, Clerk, Viatris, ARE, Settlement, Counsel, Court of Common Pleas, Pfizer, Court, Hearing, Law, Generic drug

your rights MAY be affected by a class action lawsuit pending in this court.

Key Points: 
  • your rights MAY be affected by a class action lawsuit pending in this court.
  • A hearing will be held on June 12, 2024 at 1:00 p.m. Eastern Time, before the Hon.
  • Please do not contact the Court, the Clerk's office, Viatris, the other Defendants, or their counsel regarding this notice.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

O3 Mining Sells Its Louvem Property to Eldorado Gold

Retrieved on: 
Monday, March 11, 2024
Mining, Agreement, Val-d'Or, Corporation, Sale, Acquisition, NSR, El Dorado, OTCQX

TORONTO, March 11, 2024 /PRNewswire/ - O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) ("O3 Mining" or the "Corporation") is pleased to announce that it has completed the sale of its Louvem Property to Eldorado Gold (Québec) Inc. ("Eldorado Québec").

Key Points: 
  • TORONTO, March 11, 2024 /PRNewswire/ - O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) ("O3 Mining" or the "Corporation") is pleased to announce that it has completed the sale of its Louvem Property to Eldorado Gold (Québec) Inc. ("Eldorado Québec").
  • O3 Mining has agreed to sell to Eldorado Québec a 100% interest in its Louvem Property located in Val-d'Or, Québec, Canada, in exchange for cash consideration of C$80,000 and the retention by O3 Mining of a 0.5% Net Smelter Return ("NSR") royalty payable to the Corporation on all metal production from the claims constituting the Louvem Property ("Louvem NSR").
  • The Corporation originally acquired the Louvem Property from Monarch Gold Corporation ("Monarch") pursuant to an asset purchase agreement dated March 16, 2020.
  • For additional information regarding the acquisition of the Louvem Property by the Corporation, see the press release " O3 Mining Acquires Interests in the Regcourt and Louvem Properties from Monarch Gold ", dated March 17, 2020.

Farmers’ protests: why EU wants to increase tariffs on Russian imports but won’t impose sanctions

Retrieved on: 
Wednesday, April 3, 2024
Health, Tax, Farmer, Face, GATT, Agreement, Lifting, Agriculture, Financial Times, Risk, European Green Deal, Food, World Trade Organization, United, Real-time, Heart, European Commission, Government, Developed country, Reuters

The increased duties will apply to imports of cereals, oilseeds and related products from Russia and Belarus.

Key Points: 
  • The increased duties will apply to imports of cereals, oilseeds and related products from Russia and Belarus.
  • But they are designed to allow unhindered passage through EU countries.
  • As an EU press release put it: “Importantly, the proposed tariffs will … not affect global food security, particularly for developing countries.
  • On this basis, the EU has decided to introduce restrictions with a view to reducing the access of Russian grain to its internal market.

Fine balance

  • Or put another way, how to address Polish farmers’ protests about EU imports of Ukraine grains, which are hurting the internal EU market.
  • The call was not about how to punish Russia, although it could be argued the two are inextricably linked.
  • To ease tensions with Poland, Ukraine has said it is willing to accept restrictions on its trade with the EU.

Why target Russian grain?

  • As to whether the tariffs will hurt Russia, they will – a little – if they hamper its exports.
  • As for global trade, Russia’s excess supplies are a political and market control mechanism, albeit a questionable one.
  • For the rest of the world, the concern is being able to get enough food to feed their people.


Elimma C. Ezeani does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Sun Valley Investments AG Announces Acquisition of Shares of Mineros S.A.

Retrieved on: 
Friday, March 1, 2024
Gentlemen's agreement, Shareholder, Carrera, Good, Transaction, Mercantil Servicios Financieros, Agreement, Security (finance)

The Acquired Securities represent 22.5% of the issued and outstanding common shares of Mineros.

Key Points: 
  • The Acquired Securities represent 22.5% of the issued and outstanding common shares of Mineros.
  • Immediately prior to the Transaction, Sun Valley did not beneficially own or exercise control over any common shares of Mineros.
  • Upon completion of the Transaction, Sun Valley will beneficially own and exercise control over 67,440,916 common shares of Mineros, representing 22.5% of the issued and outstanding common shares.
  • In addition, subject to certain conditions, the Shareholders Agreement may require Sun Valley to acquire additional Mineros common shares from the MC Companies.

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Monday, March 11, 2024
Research, GDF15, PSC, Part, Vomiting, Pregnancy, MSS, Liver, Atlas, Preterm birth, NGM, LAIR1, Nausea, Hospital, ILT3, GFRAL, Food and Drug Administration, NASH, Therapy, Woman, Toxicology, Liver disease, CRC, Cirrhosis, Biomarker, Place of birth, Colorectal cancer, Agreement, Acquisition, Plan, FGF19, AASLD, FDA, Food, Weight loss, Primary sclerosing cholangitis, Pembrolizumab, Dehydration, Bile, Hyperemesis gravidarum, HG, Patient, Pre-eclampsia, Malnutrition, Pharmaceutical industry

--On February 26, 2024, announced that it had entered into the Agreement and Plan of Merger with Atlas Neon Parent, Inc., and Atlas Neon Merger Sub, Inc.--

Key Points: 
  • The combination of NGM707 and pembrolizumab was generally well-tolerated at all four doses (200, 600, 1200, 1800 mg) of NGM707.
  • Additional details can be found in NGM Bio’s recent filings with the United States Securities and Exchange Commission (SEC).
  • NGM Bio anticipates that the Offer and the Merger contemplated under the Merger Agreement will be consummated in the second quarter of 2024.
  • If the Merger is effected, NGM Bio’s common stock will be delisted from The Nasdaq Stock Market LLC and NGM Bio will be privately held.

Aussie Vapes Granted Import License in Australia  

Retrieved on: 
Friday, March 8, 2024
Singular, Narrative, Aromatherapy, TGA, Minor, Nicotine, Good, Sale, Warrant, Eye, Documentation, Safety, Service, Policy, Science, Comment, Agreement, VWAP, Public

“As a leading Australian online supplier of aromatherapy products, being granted this TGA import license improves our competitive advantage even further,” said Meni Morim, CEO of Lifeist.

Key Points: 
  • “As a leading Australian online supplier of aromatherapy products, being granted this TGA import license improves our competitive advantage even further,” said Meni Morim, CEO of Lifeist.
  • Aussie Vapes has an important role to play, and we wholeheartedly support the TGA's initiatives to reduce nicotine product misuse by minors.
  • As an established market leader in Australia, Aussie Vapes recognizes that navigating the aromatherapy vaporizer import license application process presents a complicated challenge for smaller participants in the space.
  • As the new market landscape for these devices continues to evolve in Australia, Aussie Vapes will take a leading role in exploring ways to use our import license to help support smaller retailers in a fully regulatorily compliant and transparent fashion.

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

Retrieved on: 
Thursday, March 7, 2024
Vitesse, European Commission, Marketing, DBV Technologies, Blas, FDA, Form 10-K, File, Research and development, Language, Sale, BLA, Toddler, American College, Form, Financial statement, Safety, American depositary receipt, GAAP, Good news, Immunology, Administration, Net, Food, Asthma, DBV, Initiate, Development, Bank statement, Agreement, Editorial, Cryptocurrency

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023.
  • Published EPITOPE results in the New England Journal of Medicine with an accompanying editorial, entitled, Good News for Toddlers with Peanut Allergy.
  • ET to discuss full year 2023 financial results and provide a business update.
  • The conference call may be accessed by dialing:
    A webcast of the call will also be available under "Events" in the Investors section of the DBV Technologies website: https://dbv-technologies.com/investor-overview/events .

MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.

Retrieved on: 
Wednesday, March 6, 2024
OTCQB, Agreement, Investment, Telephone

VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that it has entered into an investor relations agreement (the “Agreement”) dated March 1, 2024 with Anthem Strategies Ltd. (“Anthem”), an arm’s length party to the Company.

Key Points: 
  • VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that it has entered into an investor relations agreement (the “Agreement”) dated March 1, 2024 with Anthem Strategies Ltd. (“Anthem”), an arm’s length party to the Company.
  • Pursuant to the Agreement, Anthem has agreed to provide investor relations and communications services to the Company, including digital and physical marketing outreach and related performance analysis and reporting, in consideration for an aggregate amount of US$50,000 in cash.
  • The term of the Agreement is for a period of 60 days.
  • Anthem’s business address is 4603 – 1372 Seymour Street, Vancouver BC, V6B 0L1, email: [email protected] , telephone: (778) 840-9664.

NeoGames Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, March 6, 2024
Growth, Table, Sale, Mergers and acquisitions, Development, Business analyst, North Carolina Education Lottery, Grand duchy, Partnership, OSB, Neogames, ASX, NPI, Aristocrat Leisure, Agreement, Acquisition, Georgia Lottery, ALL, Continuation, DraftKings, RSI, Bet365, Video game

LUXEMBOURG, March 06, 2024 (GLOBE NEWSWIRE) -- NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery and iGaming solutions, announced today financial results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • iLottery revenues were $14.4 million during the fourth quarter of 2023, compared to $14.5 million during the fourth quarter of 2022, representing a decrease of (0.4)% year-over-year.
  • In addition, the Company’s share in NPI revenues was $17.2 million during the fourth quarter of 2023, compared to $14.0 million during the fourth quarter of 2022, representing an increase of 22.9% year-over-year.
  • Adjusted net income1 was $1.7 million, or $0.05 per share, during the fourth quarter of 2023, compared to $7.3 million, or $0.22 per share, during the fourth quarter of 2022.
  • Adjusted EBITDA¹ was $18.2 million during the fourth quarter of 2023, compared to $18.1 million during the fourth quarter of 2022, representing an increase of 0.4% year-over-year.

Faruqi & Faruqi, LLP Announces Pendency of Class Action Involving Purchasers of Peloton Interactive, Inc. Securities

Retrieved on: 
Wednesday, March 6, 2024
Peloton Interactive, Court, Hearing, Person, Peloton, Claim, Prejudice, Episcopal conference, District court, Allocation, Party, Notice, LLP, Magistrate, Settlement, Agreement, Insurance

BROOKLYN, N.Y., March 06, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Faruqi & Faruqi, LLP regarding Peloton Interactive, Inc. Securities Litigation.

Key Points: 
  • BROOKLYN, N.Y., March 06, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Faruqi & Faruqi, LLP regarding Peloton Interactive, Inc. Securities Litigation.
  • SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT HEARING; AND (III) MOTION FOR ATTORNEYS’ FEES AND LITIGATION EXPENSES
    To: All Persons who purchased or otherwise acquired Peloton Interactive, Inc.’s (“Peloton”) securities between September 11, 2020 and May 5, 2021, inclusive, and who suffered damages thereby (“Settlement Class”).
  • The Court may change the date of the Settlement Hearing, or hold it telephonically, without providing another notice.
  • You do NOT need to attend the Settlement Hearing to receive a distribution from the Net Settlement Fund.